The second-quarter 2024 reporting cycle of the Medical sector will gain further traction this week. The sector mainly comprises pharma/biotech and medical device companies.The earnings season for the sector kicked off earlier this month, when bellwether Johnson & Johnson reported strong second-quarter results, beating on both counts. Swiss pharma giant Novartis AG also reported better-than-expected quarterly results. Last week, biotech giant Bristol-Myers also beat on its sales and earnings.Per the Earnings ...